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The angiosome concept of foot perfusion was conceived based on anatomical studies of
arterial circulation and used for planning surgical procedures, tissue reconstruction, and
amputation. Its application is relevant in diabetic patients with critical limb ischemia and
nonhealing foot ulcer or amputation. An understanding of foot angiosome anatomy is
useful for predicting healing and planning arterial revascularization. A review of the
literature, including the most recent systematic reviews and meta-analyses, indicates
improved wound healing is achieved when the angiosome concept is followed. The
greatest value of angiosome-based revascularization is in patients with lesion(s) limited to
a single angiosome, or to achieve optimal healing of amputation sites. Future research
should focus on proper identification of (imaging) modalities to determine the hemody-
namic and functional changes before and after revascularization, thus identifying the
“real” angiosome and directing optimal therapy.
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).comorbidities [3]. Incisional wound healing in diabetic pa-
1. Introduction
The incidence of critical limb ischemia (CLI) is increasing, and
diabetic patients are especially prone to developing ischemic
and neuro-ischemic foot ulcers. Twelve to 25% of diabetic
patients may develop a foot lesion over time [1]. Diabetic pa-
tients often present withmore extensive tissue loss compared
to non-diabetic patients [2]. The importance of revasculari-
zation of the lower limb in patients with CLI has been well
established, and expedited revascularization is mandatory
once an ischemic foot ulcer is detected. Although there is still
a role for surgical bypass, over the last several decades the use
of endovascular techniques has become more frequent. This
development has been made possible by the evolution of
endovascular devices and operator skills. The less-invasive
endovascular approach is the preferred treatment method,
especially in the frail diabetic patient with multiple.C. van den Berg).
.002
y Elsevier Inc. This istients can also be problematic [4]. In both open and endovas-
cular revascularization there is a clear difference of approach
in patients with CLI caused by inflow disease (iliac, femoral,
and popliteal disease) and those with (additional) infrapopli-
teal involvement. Whereas in above-the-knee disease, it is
clear that flow in the stenotic or occluded segment needs to be
re-established, in below-the-knee (BTK) disease, potentially
three vessels can be revascularized, and this poses a thera-
peutic dilemma (especially for open revascularization).
Choosing the correct target for revascularization can present a
critical, complex issue in challenging cases, especially when
multilevel arterial disease is present [1]. Revascularization can
be accomplished by using two approaches: “complete”
revascularization (one vessel is better than none, two to three
vessels are better than one) or “wound-related” revasculari-
zation [1]. With CLI, the healing of an ulcer is blood-flowe
dependent and the goal of treatment should be to get the bestan open access article under the CC BY-NC-ND license (http://
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Legends for ﬁgure 1
1. Anterior bial artery
2. Medial plantar artery of posterior bial artery
3. Lateral plantar artery of posterior bial artery
4. Lateral calcaneal branch of peroneal artery
5. Medial calcaneal branch of posterior bial artery
6. Peroneal artery
7. Posterior bial artery
8. Dorsalis pedis artery of anterior bial artery
Fig. 1 – Schematic drawings of the foot showing six angiosomes based on anterior tibial, posterior, and peroneal arteries.
Adapted from [15].
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feasible, and in order to guide the choice of which BTK vessel
should be revascularized, the angiosome concept has been
proposed, based on the idea that specific anatomical regions
are perfused by specific arteriovenous bundles. The concept
has been used for planning surgical access, tissue recon-
struction, and amputation [5]. This article will discuss the
angiosome concept and its application in patients with CLI,
and will provide a review of the current literature.2. The angiosome concept
The angiosome concept has been conceived based on
anatomical studies in plastic reconstructive surgery [6]. The
term angiosome is derived from the Greek angio- meaning
vessel, and somite meaning segment or sector of the body
(derived from soma meaning body). These studies identified
three-dimensional blocks of tissue (consisting of skin, sub-
cutaneous tissue, fascia, muscle, and bone) that are perfused
and drained by specific angiosomal vessels.
In the region of the ankle and the foot, there are six
angiosomes that emerge from the three main BTK arteries
(anterior and posterior tibial artery and the fibular [peroneal]
artery) [7]. Primary supply to the skin originates from direct
cutaneous arteries, and these are reinforced by small, indirect
branches from arteries that supply the deeper lying areas. Inhealthy subjects, two types of anastomotic arteries create a
compensatory pathway between the various angiosomal ter-
ritories: reduced-caliber (“choke”) and similar-caliber (“true”)
anastomotic arteries that provide a redundant conduit
allowing a certain angiosome to receive blood from a neigh-
boring angiosome in case of occlusion of the original source
artery [6]. The choke vessels demarcate the border of each
angiosome [8].The longer a patient suffers from diabetes, the
more these choke vessels will be compromised and the less
collateralization can occur. In addition to the choke vessels,
direct arterialearterial connections between angiosomes exist
and these connections play an important role in compen-
sating for ischemic events that occur in a neighboring angio-
some [8]. As the collateral capacity is negatively affected by
occlusive disease of the foot arteries, angiosome-targeted and
more distal selective revascularization can be expected to
improve outcomes [5,8].
There are six foot angiosomes, including three angiosomes
originating from the posterior tibial artery, one angiosome
from the anterior tibial artery, and two angiosomes from the
peroneal artery [9] (Fig. 1). The following description is based
on a paper by Clemens and Attinger [10].
2.1. Posterior tibial artery angiosomes
At the level of the foot, the posterior tibial artery gives off the
posterior medial malleolar branch at the level of the medial
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anterior medial malleolar branch from the anterior tibial
artery, giving rise to an important interconnection between
the posterior tibial artery and the anterior tibial artery. This
system supplies the medial malleolar area. At the same level,
themedial calcaneal artery originates from the posterior tibial
artery inferiorly and divides into multiple branches that sup-
ply the heel. The angiosome boundary of themedial calcaneal
artery includes the medial and plantar heel, with its most
distal boundary being the glabrous junction of the lateral
posterior and plantar heel. The posterior tibial artery then
runs through the calcaneal canal (below the flexor retinac-
ulum) and bifurcates into the medial and lateral plantar ar-
teries. The angiosome boundaries of themedial plantar artery
encompass the so-called “instep.” The boundaries of this
angiosome are posteriorly the distal-medial edge of the
plantar heel, on the lateral side the midline of the plantar
midfoot; distally the proximal edge of the plantar forefoot; and
medially a curved line that runs 2 to 3 cm above the medial
glabrous junction. The medial plantar artery has two main
branches: the superficial and deep branches. The superficial
branch has interconnections with the anterior tibial tree:
cutaneous braches connect proximally withmedial cutaneous
branches from the dorsalis pedis artery and distally with
branches of the first dorsal metatarsal artery. More plantarly
and laterally, the superficial branch of the medial plantar ar-
tery joins with the deep branch of the medial plantar artery
and the first plantar metatarsal artery (which is a branch of
the lateral plantar artery). The deep branch of the medial
plantar artery has perforating branches that supply the
medial sole of the foot. At the neck of the first metatarsal, it
anastomoses with the first plantar metatarsal artery and/or
the distal lateral plantar artery. The angiosome of the lateral
plantar artery includes the lateral plantar surface as well as
the plantar forefoot. It is bordered posteriorly by the distal
lateral edge of the plantar heel, medially by the central raphe
of the plantar midfoot, more distally by the glabrous juncture
between the medial plantar forefoot and the medial distal
dorsal forefoot, and laterally by the glabrous junction between
the lateral dorsum of the foot and the plantar surface of the
foot. The distal border includes the entire plantar forefoot.
The hallux is usually part of the lateral plantar angiosome, but
it can also be part of themedial plantar artery angiosome or of
the dorsalis pedis angiosome. The lateral plantar artery
anastomoses directly with the dorsalis pedis artery distally in
the proximal first interspace. This direct anastomosis be-
tween the dorsal and plantar circulation helps ensure that if
either the proximal dorsalis pedis or lateral plantar artery
becomes occluded, flow is maintained to the entire foot. The
four plantar metatarsal arteries originate from the deep
plantar arch to nourish the plantar forefoot.
2.2. Anterior tibial artery angiosome
The anterior tibial artery nourishes the dorsalis pedis angio-
some that perfuses the dorsal aspect of the foot and toes as
well as the upper anterior peri-malleolar vessels. At the level
of the lateral malleolus, the anterior tibial artery gives off the
lateralmalleolar artery that joinswith the anterior perforating
branch of the peroneal artery. At the same level, it also givesoff the medial malleolar artery, which anastomoses with the
posteromedial malleolar branch of the posterior tibial artery.
The anterior tibial artery becomes the dorsalis pedis artery
once it crosses the extensor retinaculum of the ankle. The
angiosome of the dorsalis pedis artery encompasses the entire
dorsum of the foot. This artery has connections with the su-
perficial medial plantar artery medially, the calcaneal branch
of the peroneal artery proximolaterally, and the lateral plantar
artery and its perforators in the proximal metatarsal in-
terspaces. The dorsalis pedis artery is absent or extremely
attenuated in 12% of cases, and there are many anatomic
variations to its course. Typically, the dorsalis pedis artery has
three lateral arterial branches (the proximal and distal tarsal
arteries and the arcuate artery) and two medial branches (the
medial tarsal arteries). The proximal lateral tarsal artery
communicates with the calcaneal branch of the peroneal ar-
tery and it may also connect with the lateral malleolar artery
and the arcuate artery. The third lateral branch of the dorsalis
pedis, the arcuate artery, takes off at the level of the first
tarsalemetatarsal joint and travels laterally over the bases of
the second, third, and fourth metatarsals. It gives off the
second, third, and fourth dorsal metatarsal arteries before it
joins the lateral tarsal artery. Medially, the dorsalis pedis ar-
tery (usually) gives off two medial tarsal arteries.
2.3. Peroneal artery angiosomes
The peroneal artery bifurcates (forming a delta) into the
anterior perforating branch and the lateral calcaneal branch
emerges at the level of the lateral malleolus, before it emerges
at the level of the lateral malleolus. The peroneal artery pro-
vides blood supply to the lateral calcaneal angiosome,
responsible for the perfusion of the lateral and plantar aspect
of the heel and the anterior perforator angiosome (providing a
connection of the anterior peroneal perforating branch to the
anterior tibial territory; perfusion of the lateral anterior upper
ankle). The proximal boundaries of the angiosome of the
lateral calcaneal branch extend medially to the medial
glabrous junction of the heel, distally to the proximal fifth
metatarsal, and superiorly to the lateral malleolus. The lateral
calcaneal artery terminates at the level of the fifth metatarsal
tuberosity, where it connects with the lateral tarsal artery.
The heel has two overlapping source arteries: the medial and
lateral calcaneal arteries, ensuring duplicate blood supply to
an area that is regularly traumatized during ambulation.
Anatomical variants of the above-mentioned anatomy are
common, and may occur in up to 16% of cases [11].3. Application of the angiosome concept in
clinical practice
When discussing the angiosome concept, it should be kept in
mind that the concept is an anatomic description rather than
a physiologic model [12]. Arterialearterial connections allow
for blood flow to the entire foot even when one or more ar-
teries are occluded [10]. Angiosome-oriented revasculariza-
tion has gained attention and its application has resulted in
higher rates of limb salvage and wound healing [1]. However,
many factorsmust be considered in choosing the target artery
Fig. 2 – Photo of forefoot showing ulcer on dorsum of the
foot (arrow) and location of pulse of dorsalis pedis artery
(arrowhead); note signs of skin and toe ischemia. The
location of the ulcer precludes a dorsalis pedis bypass.
Fig. 3 – Left: angiographic images of foot shown in Figure 1
showing patency of peroneal and posterior tibial artery;
occlusion of the anterior tibial artery and faint
enhancement of the dorsalis pedis artery (arrowhead).
Right: after endovascular treatment antegrade flow in the
anterior tibial and dorsalis pedis artery (arrowheads) is
demonstrated.
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part of this [13].
It has been suggested that in diabetic patients, the occur-
rence of (neuro-)ischemic problems (the so-called “diabetic
foot”) is related to a combination of distal atherosclerotic
macroangiopathy and an impairment of the functionality of
the microcirculation (the latter induced by neuropathy and
local sepsis) [9,14]. Huge collateral depletion, as seen in dia-
betic patients and those with end-stage renal disease, jeop-
ardize the natural “rescue system” between the angiosomes
[15]. Collateral reserve is depending on aging, the underlying
pathology that causes CLI, and the location of the angiosome
itself (the two extremes are the atherosclerotic, non-diabetic
middle-aged patient with forefoot trophic lesions and, on
the other hand, the aged, long-lasting diabetic or renal patient
with neuro-ischemic heel tissue defects). In patients with
diabetic end-artery disease, so-called “patchy atherosclerosis”
occurs, with acute septic thrombosis and loss of small col-
laterals [5]. The absence of collateral vessels underscores the
need for a more distal, selective, revascularization that im-
proves perfusion at the level of the skin [5].
Whereas in surgical revascularization, oftentimes themost
suitable vessel for revascularization needs to be chosen (not
necessarily the artery that directly supplies the angiosome
involved), endovascular revascularization offers the advan-
tage that the specific angiosome can be targeted (although this
may require lengthy and cumbersome, not always successful,
procedures) [9], and multiple BTK and even below-the-ankle
vessel reconstructions can be performed [5]. Bypass still
holds an important role because it will yield higher local
pressure and physiological pulsatile flow [15]; however,
endovascular therapy offers the option to openmore than one
tibial vessel. Angiosome-guided bypass surgery is not
always possible because of the presence of infection, exten-
sive tissue loss (especially when at or near the anastomotic
site (Figs. 2 and 3), and severe arterial disease [16]. Both sur-
gical and endovascular procedures may be hampered by the
presence of medial sclerosis, with diffuse calcification, that
may render the most appropriate (angiosome-related) arteryalso the most difficult to treat. This problem was limiting
endovascular direct revascularization in the past [3], but with
themore frequent use of dedicated endovascularmaterial and
the more liberal use of retrograde access this technical limi-
tation is probably less of an issue today.
Clinical reports suggest an advantage of direct revascu-
larization, and its importance in diabetic patients is thought to
be greater due to the different underlying pathophysiology. In
diabetic patients, the tunica media is affected rather than the
intima, leading to a situation where not only the source artery
but also collaterals and anastomoses between angiosomes are
affected [2]. It must be kept in mind that indirect revascular-
ization can be adequate when sufficient collaterals are pre-
sent (Figs. 4 and 5) [17]. In fact, critics of the angiosome
concept suggest that the chronic, progressive nature of pe-
ripheral arterial disease leads to the development of collateral
arterial connections between the feeding vessels and the
wound area [18].
In the diabetic patient, additional factors that influence
outcome are peripheral autonomic denervation and regional
sepsis, which both cause additional local hemodynamic
changes. Endothelial dysfunction results in significant in-
flammatory changes of the arterial wall and atherosclerosis,
and also vascular smooth muscle cells become dysfunctional,
which accelerates the process.Microvascular dysfunction also
has effects on the autonomic nervous system, with loss of
autoregulatory function, an impaired hyperemic and inflam-
matory response, loss of the neurogenic regulatory response,
loss of the vasoconstrictor response, increased arteriovenous
shunting, impaired oxygen diffusion, and leukocyte migra-
tion. These regulatory functions and responses are essential
Fig. 5 – Angiographic image after recanalization and
balloon angioplasty of the anterior tibial artery showing
patency of the proximal anterior tibial artery and a
significant increase in wound blush.
Fig. 4 – Angiographic images of a diabetic patient with a
lateral mal perforans ulcer showing occlusion of anterior
tibial artery (arrowhead) and tibioperoneal trunk (arrow),
absence of distal filling of peroneal and posterior tibial
artery.
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sequence and contribute to faulty wound healing in patients
with diabetes. Microvascular dysfunction is not an occlusive
phenomenon and supports an aggressive approach to treating
existing macrovascular atherosclerotic occlusive disease
complicating diabetic wounds of all extremities combined
with optimal management of diabetes, wound care, systemic
infection, and other known risk factors [14].
The feasibility of angiosome-targeted endovascular revas-
cularization and the number of angiosomes involved was
evaluated retrospectively in 161 patients (the majority with
diabetes). Only 24% of patients had involvement of a single
angiosome (47% has two angiosomes, 26% had three angio-
somes, 2% had four angiosomes, and 1% had five angiosomes).
Direct flow in the involved angiosome could be achieved in
60.9% of all cases (although it was considered to be feasible in
80.1% of cases, indicating a relatively high failure rate). If the
lesion was limited to one angiosome, direct revascularization
could be achieved in 69.2% of cases, with extension of the
ulcer into two angiosomes this was possible in 86.7% of cases,
with three angiosomes involved in 85.7%. When four angio-
somes were involved in only one-quarter of the patients,
direct revascularization was possible, and in those patients
with an involvement of more than five angiosomes, direct
revascularization was not possible at all. In the series from
Rashid [19], direct revascularization was feasible in only 47%
of cases. In the study from Zheng et al [20], 20% of the patients
could not undergo angiosome-oriented revascularization due
to occlusion with severe calcification or technological diffi-
culties. Because of the frequently present extension of awound in diabetic patients beyond one angiosome, deter-
mining which vessel to target for may be less straightforward
than anticipated [21]; classification of wounds proved ambig-
uous in 23.3%. In the same group of patients, multiple wounds
with dispersion over several angiosomeswere present in 8.6%.
Perfusion studies using tissue oxygen saturation foot-
mapping have shown that there is no perfect correlation
with the classical angiosomes [22]. The technique was able to
identify areas of ischemia, and can be used to evaluate what
the authors have called the “real” angiosome. The angiosome
model is not always able to describe the actual distribution of
peripheral tissue perfusion because the blood flowdepends on
additional factors, such as the development of collaterals and
vascular abnormalities at the capillary and microvascular
plexus level. The “real” angiosome model takes into account
both collateral development and anatomical variants. In
obtaining tissue healing revascularization alone is not suffi-
cient. Therefore, multidisciplinary care that addresses proper
wound care, control of local neuropathy, diabetes regulation,
and treatment of local sepsis is mandatory [23].4. Does angiosome revascularization
improve healing?
Several meta-analyses have been published recently on the
topic of angiosome-targeted revascularization and, hereafter,
an overview of these and single-center series will be given. No
randomized trials comparing direct revascularization to in-
direct revascularization have been performed and, given the
complexity of the disease entity, this will probably never be
feasible [18]. The validity of the angiosome concept in the
treatment of CLI remains controversial, and whether better
wound healing and limb preservation is achieved using a
direct (angiosome-based) revascularization approach remains
a topic of debate. It must be kept in mind that the angiosome
S E M I N A R S I N V A S C U L A R S U R G E R Y 3 1 ( 2 0 1 8 ) 5 6 e 6 5 61concept has been developed in “healthy” subjects, in the
absence of peripheral vascular disease, and that direct
revascularization is not always possible [24].
4.1. Single-center studies
In a study focusing on endovascular treatment in isolated BTK
disease, it was found that amputation-free survival and
freedom from major adverse limb events out to 4 years was
significantly lower in patients that underwent indirect revas-
cularization. It was also found that factors associated with
major amputation in the direct group (high hemoglobin A1c
level [indicating poor glycemic control] and cilostazol
administration) were different from those in the indirect
group (high C-reactive protein level, indicating infection) [3]. It
was also found that the presence of three BTK runoff vessels
at the end of the procedure resulted in the best limb salvage
rate in the overall cohort (freedom frommajor amputation at 3
years overall and according to number of patent runoff of 86%
for three v 63% for one). Comparing patients with three-vessel
runoff and those with direct revascularization (irrespective of
the runoff status) showed no significant difference in freedom
from amputation.
Evaluation of the endovascular treatment of 250 legs with
diabetic foot ulcers comparing direct and indirect revascu-
larization showed significantly better healing rates at 6 and 12
months for the direct revascularization group [4]. After
multivariate analysis, direct in-line flow was found to be the
only significant independent predictor for ulcer healing. The
authors' postulate the reason for improved healing was the
loss of “choke” vessels in this diabetic population. The study
of Iida et al [25] demonstrated that wound healing is better
when performing a direct revascularization as compared to
indirect revascularization, while the occurrence of major
adverse limb events and amputation rates remained
unaffected.
In patients undergoing distal bypass surgery, it was found
that the healing rate in the indirect revascularization group
was significantly slower than in the direct revascularization
group (especially in patients with end-stage renal disease)
[16]. Using propensity score analysis, it was found that healing
rates were similar. These outcomes are in contrast with a
recent study from Spillarova et al [26], who found that end-
stage renal disease, diabetes, Rutherford category 6, and low
albuminemia were negative predictors of wound healing. This
underscores the need for a multidisciplinary approach when
correction of metabolic abnormalities when present. When
direct versus indirect revascularization was evaluated in pa-
tients with combined endovascular and surgical treatment,
the highest wound healing rate was achieved after direct
surgical bypass to an angiosome artery, and the lowest with
indirect angioplasty. In this study, there was a difference in
type of lesions/patient treated: balloon angioplasty was per-
formed as first-line treatment in patients with short occlu-
sions and stenotic lesions and to patients with an increased
risk of undergoing bypass surgery or without an available
autologous vein. This may have introduced a certain bias in
the evaluation of the results. In this study, a sub-analysis of
collaterals was performed. The presence of collaterals was
graded as good or non-existent, and patientswere divided intothree groups: direct revascularization (in the surgical group in
66.8% of cases, in the endovascular group in 56.5%), indirect
revascularization with good collaterals (in the surgical group
in 12.2% of cases, in the endovascular group in 30.8%), and
indirect revascularization with no collaterals (in the surgical
group in 21% of cases, in the endovascular group in 12.7%). The
endovascular group underwent more frequently a re-
intervention. A univariate analysis demonstrated that C-
reactive protein <10 mg/dL, hypercholesterolemia, the type of
procedure, and the number of affected angiosomes fewer than
three were associated with amputation-free survival. The
latter seems to be a logical and foreseeable outcome because
the involvement of fewer than three angiosomes indicates the
presence of less-extensive disease. This is in line with the
findings of the same group at an earlier point in time [27]. On
the other hand, increased age, chronic heart failure, chronic
kidney disease, hemodialysis, atrial fibrillation, and chronic
obstructive pulmonary disease were associated with
decreased amputation-free survival. Direct bypass, indirect
bypass, and direct percutaneous transluminal angioplasty, as
opposed to indirect percutaneous transluminal angioplasty,
were independent predictors of amputation-free survival.
After surgical bypass, there was no difference between direct
and indirect revascularization in wound healing and limb
salvage. Leg salvage was similar after direct endovascular
revascularization and direct/indirect surgical bypass. Some
studies have suggested that the success of wound healing
depends on the quality of the pedal arch, but this could not be
reproduced in this study (no difference in outcome complete
and incomplete arch).
Direct revascularization to pedal angiosomes using bypass
with autogenous vein leads to amore efficient wound healing,
with the caveat that this type of revascularization is only
possible in around 50% of patients [28]. In this study, the
location could be assigned to only one single angiosome in
only 36% of wounds. Although direct revascularization was
shown to improve wound healing, there was no influence on
amputation-free survival. Faster wound healing might, how-
ever, contribute to better quality of life, aswell as to a decrease
of costs related to wound care. Pedal arch quality did not in-
fluence healing and infrapopliteal bypass outcome in a study
that investigated the effect of direct revascularization in the
presence of a complete or incomplete pedal arch [19]. Direct
revascularization led to significantly shorter healing times in
patients without a pedal arch only. Endovascular reconstruc-
tion of the pedal arch can probably reduce the time to healing
in these patients.
An evaluation of 64 patients with only a single vessel
crossing the ankle treated with direct or indirect revasculari-
zation (by either surgical or endovascular means) showed a
benefit of direct revascularization in terms of wound healing,
but failed to demonstrate a difference in limb salvage rate [29].
Comparing the mean time to complete healing in a cohort of
56 patients with 60 wounds, no statistically significant dif-
ference was seen between direct and indirect (bypass) revas-
cularization [13]. However, wound healing rates were
significantly better in the direct revascularization group
(90.9% v 61.9% for the indirect revascularization group). In the
indirect revascularization group, a significantly higher major
amputation rate was seen. In contrast to these findings, Lejay
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isolated BTK bypasses) found a shorter median ulcer-healing
time after direct revascularization, with similar survival and
primary patency. Limb salvage rate was also higher in the
direct group. In this study, all patients in the indirect group
only had one crural artery, which may have influenced
outcomes.
A study from France that reported on the outcomes of 157
endovascular procedures (slightly more than half of these
procedures were limited to the infrapopliteal segment alone)
showed favorable long-term results and failed to demonstrate
any impact of the angiosome concept on clinical success [31].
The fact that multi-segment pathology was treated in slightly
fewer than half of the patients may have confounded the
outcome (for this reason, this study was probably excluded
from the most recent meta-analysis described hereafter). The
results of an evaluation of 486 patients that were treated by
endovascular means where categorization into three groups
was performed (direct revascularization, indirect revascular-
ization through collaterals, and indirect revascularization
without collaterals) [20], showed that during the 1-year follow-
up, the unhealed ulcer rate of the indirect revascularization
without collaterals was significantly higher, and the limb
salvage rate was significantly lower than in the other two
groups. There were no differences in the unhealed ulcer rate
or the limb salvage rate between the direct revascularization
group and the indirect revascularization through collaterals
group. Within the group of indirect revascularization without
collaterals, the unhealed ulcer rate of diabetic patients was
higher than that of patients without diabetes, but there was
no difference in the limb salvage rate between diabetic and
nondiabetic patients. No differences in the unhealed ulcer
rate or the limb salvage rate were found between diabetic and
nondiabetic patients in the other two groups. This study also
evaluated the reintervention rate at 1 year and found that
there was no statistically significant difference in the per-
centage of reintervention between direct revascularization
and indirect revascularization through collaterals, while in-
direct revascularization without collaterals led to significantly
more reinterventions (compared to the other two strategies).
Collateral vessels play a more important role in CLI accom-
panied by diabetes than in simple atherosclerotic CLI.
Angiosome research has focused on healing comparison of
direct versus indirect revascularization. However, in clinical
practice, both approaches are used in some patients. This so-
called combined revascularization can be achieved in around
10% of cases [32]. Amputation-free survival and the combined
re-intervention and amputation-free survival were signifi-
cantly improved compared to indirect revascularization in
this study involving 250 subjects. Wound healing rates were
similar, and in diabetics, no differences were seen regarding
amputation-free survival and re-intervention rates.
4.2. Systematic reviews and meta-analysis
Over the last few years, several systematic reviews have been
published and their conclusions are not equivocal, just like
the single-center studies described here.
The first systematic review, dating back to September 2013,
evaluated 11 studies, involving 1,616 patients and 1,757 limbs[33]. The authors noticed an important heterogeneity of the
published data, not only with regard to the technique used,
but also the definition of direct revascularization, follow-up,
and reporting of outcome. They emphasize the lack of pro-
spective trials; large patient populations; and a consistent,
uniform vocabulary to compare study findings. All of these
factors prevent (according to the authors) a recommendation
of the conceptual model for the guidance of revascularization
attempts at a wider level.
The second published review (January 2014) included a
total of nine studies (of note, fewer studies were included
compared to the review mentioned previously) [8]. A total of
715 legs were treated using a direct approach, while 575 legs
were treated with indirect revascularization. The risks of un-
healed wound andmajor amputation were significantly lower
after direct revascularization compared with indirect revas-
cularization. Pooled limb salvage rates after direct and indi-
rect revascularization were 86.2% versus 77.8% at 1 year and
84.9% versus 70.1% at 2 years, respectively. The analysis of
three studies reporting only on patients with diabetes
confirmed the benefit of direct revascularization in terms of
limb salvage. Amputation-free survival (evaluated only in two
of the included studies) showed a trend in favor of direct
revascularization. When feasible, direct revascularization of
the foot angiosome affected by ischemic tissue lesions may
improvewoundhealing and limb salvage rates comparedwith
indirect revascularization. A limitation of all of the studies
evaluated was their retrospective nature, with a lack of proper
comparability of the studies. Not having data on the angio-
graphic status of the foot arteries limits the analysis of the
data further andmost data involve diabetic patients,making it
uncertain whether angiosome-targeted revascularization is
also of benefit in non-diabetic patients. Therefore, additional
studies of better quality and adjusted for differences between
the study groups are needed. An invited commentary to this
review underscores the fact that the angiosome model was
developed in healthy subjects and that the actual distribution
of angiosomes may be different in patients with CLI [24].
The third review, published in May 2014, included 15
cohort studies (that reported on 1,868 limbs), including both
endovascular and surgical revascularization [17]. The quality
of evidence was low or very low for all outcomes evaluated.
All studies were retrospective and observational in nature.
None of the included papers used a standardized revascu-
larization decision-making algorithm. Compared to indirect
(not angiosome-related) revascularization, patients that un-
derwent direct revascularization were significantly more
likely to be revascularized to the anterior tibial and dorsalis
pedis artery and significantly less likely to the peroneal artery
(this may be a confounding factor). Direct revascularization
was associated with improved wound healing rates
compared with indirect revascularization, and also demon-
strated significantly improved limb salvage rates. Wound
healing and limb salvage were improved for both open and
endovascular intervention. There was no effect on mortality
or the incidence of reintervention between the two methods
of revascularization. The improved outcomes seen when
performing direct revascularization can probably be
explained by the absence of adequate collaterals between the
angiosomes. In cases where good collaterals are present,
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outcomes. This underscores the necessity to more aggres-
sively target for direct revascularization in the absence of
collaterals. In addition, as mentioned, combining indirect and
direct revascularization has been demonstrated to lead to
better outcomes [34]. This meta-analysis suggests that in
patients where both options of the direct and indirect
approach are feasible, direct revascularization should be the
preferred approach.
The fourth meta-analysis selected only 4 of 518 publica-
tions [35]. The largest number of paperswas excluded because
they were duplicate publications or papers from an institution
describing an increasing number of patients in prospectively
recruited cohorts in various papers. This review was also
limited to diabetic patients treated by endovascular means. It
was found that both the overall limb salvage rate and wound
healing were significantly better after angiosome-targeted
angioplasty.
The most recent systematic review and meta-analysis
enrolled studies including open and endovascular revascu-
larization, as well as diabetic and non-diabetic patients with
CLI [36]. A total of 19 cohort studies (with 3,932 patients) were
evaluated. Nine of these were considered as high quality. It
was found that direct revascularization led to significantly
better wound healing. Direct revascularization in bypass
studies did not show a reduction of major amputations
compared to indirect revascularization. A significant reduc-
tion of major amputations was seen in high-quality studies,
and those studies evaluating endovascular treatment. Sur-
vival rates were similar. In 3 of 19 studies, a stratification was
made for collaterals. In the presence of collaterals, no differ-
ences in wound healing andmajor amputation rate were seen
between angiosome-targeted and non-angiosomeetargeted
revascularization.5. Conclusions
Predicting diabetic foot healing based on angiosome perfusion
remains a matter of debate, and only a randomized trial will
be able to answer this clinical question definitively. Current
studies (including the systematic reviews) show inconsistent
methodology; heterogeneity; lack of definition; and (especially
in the earlier reviews) a different number of studies included,
although the same number was probably available for evalu-
ation. The focus of the angiosome concept has been on
revascularization, but it should be kept in mind that there is
also a significant role in determining safe incisions in normal
and vascular compromised patients [10]. Today there is a
better understanding of the role of the “choke” vessels in
diabetic and renal patients, the importance of the foot arches
and large arterialearterial collaterals, and the key role of
metatarsal perforators [37]. Distinctions should be made be-
tween direct, indirect via arterialearterial connections, and
“pure” indirect revascularization. In the latter, healing will
depend on whether choke vessels eventually open up or not
[38]. The importance of direct revascularization depends on
the way the arterial outflow is preserved, and even indirect
revascularization through collaterals may provide results
similar to those of direct revascularization. Probably thegreatest value of angiosome-based revascularization is for
patients in which the lesion is limited to a single angiosome,
or in cases where healing of postsurgical amputation wounds
is needed (in these cases, the connection between the dorsal
and plantar circulation has been interrupted). The concept
may be less relevant for endovascular revascularizations
because, in contrast to bypass surgery, it offers the option to
reopen multiple vessels [4]. In the various studies presented,
the patients who undergo angiosome-targeted revasculariza-
tion as opposed to non-targeted revascularization are
different with regard to age, comorbidities, and severity of
peripheral arterial disease. Oftentimes patients are too fragile
for open surgery, and thus the only option is endovascular
revascularization. Furthermore, in a large proportion of pa-
tients, the target vessel for revascularization cannot be cho-
sen, as there may be only one crural vessel left, while the
wound affects several angiosomal regions. Therefore, in the
minority of cases, it is possible to choose between angiosome-
targeted and non-angiosomeetargeted revascularization or
between percutaneous transluminal angioplasty and open
bypass. It is therefore beneficial to be able to offer both
methods of revascularization. Whenever there is a possibility
to achieve angiosome-targeted revascularization, endovas-
cular treatment is the best option. If not, however, the best
option seems to be bypass surgery, regardless of the angio-
somal orientation [27]. When choosing between surgical and
endovascular revascularization, the completely different
levels of invasiveness of the procedures must also be kept in
mind. In view of the inflow interruption to the periphery and
blood loss as a result of open surgery, endovascular proced-
ures are not just less invasive to the patient, but they also have
a lower risk of postoperative infection, as well as shorter
hospitalization time.
Challenges for proper implementation of the angiosome
concept are twofold. First, a change of mindset should occur,
letting perfusion of an affected area prevail over the recon-
stitution of perfusion of the most suitable artery. Second,
anatomical variations of the main angiosome boundaries
occur occasionally [5]. When using the angiosome concept,
the definition of angiosome-targeted (direct) revascularization
is of critical importance. In the literature, two definitions of
direct revascularization in patients with a foot ulcer spreading
over the forefoot and heel are used, and when different defi-
nitions are used, different outcomes may be seen [39]. In
definition A, direct revascularization is considered to be per-
formed if any of the affected angiosomes are revascularized
(eg, a lesion of the tip of the toes can either be revascularized
through the anterior tibial/dorsalis pedis artery or posterior
tibial/plantar artery). Definition B accepts one angiosome
revascularization only (in the case of a forefoot lesion only the
posterior tibial/plantar artery should be considered). In this
specific study, the use of definition B yielded a direct revas-
cularization rate of only 30%, and when using definition A, the
ratewent up to 56%.When looking specifically at the impact of
the two different definitions, it was noted that definition A of
direct revascularization was associated with significantly
better wound healing and lower amputation rates, whereas
definition B was associated with significantly better wound
healing only. It can therefore be concluded that if the wound
spreads out over more than one angiosome (in the forefoot or
S E M I N A R S I N V A S C U L A R S U R G E R Y 3 1 ( 2 0 1 8 ) 5 6 e 6 564heel), any angiosomal artery can be targeted in order to ach-
ieve a better outcome. This is a very important finding because
the majority of studies does not report the number of affected
angiosomes, or provides insight in the definition used.
Important factors that should be considered when plan-
ning the treatment are the number of affected angiosomes
and C-reactive protein level [27]. Five factors inhibit wound
healing after revascularization [16]:
1. location and extent of ischemic tissue defects
2. systemic factors relating to wound healing ability and the
defense system
3. infection
4. inadequate topical treatment
5. insufficient blood supply due to inadequate
revascularization
In all cases, delay of treatment should be avoided: longer
standing infection and the related elevation of C-reactive
protein are known factors that influence outcomes negatively.
The threshold for intervention in diabetic patients with a foot
ulcer should be lower than that for non-diabetic patients [4]. If
technically feasible, direct revascularization is probably the
best way to achieve appropriate wound healing because it will
provide optimal macro- and microcirculatory conditions for
tissue regeneration. This is especially the case in patients with
end-stage renal disease and diabetic patients in whom
collateral circulation is often compromised. Reconstitution of
macrocirculation should also focus on re-opening of foot
arches and large collaterals. Achieving pulsatile arterial flow
straight to the site of the ischemic wound is of critical
importance to effectively treat wound infection, to accelerate
the healing process, and to avoid limb loss [8].
As mentioned previously, in all studies outcomes have not
been well defined, and there may be a need for more objective
evaluation of the hemodynamic changes by using skin
perfusion pressure measurement, hyperspectral imaging,
indocyanine green staining, or two- or three-dimensional
perfusion angiography [16,33]. Recent research measuring
microperfusion using light-guided Doppler flowmetry
demonstrated that there was global improvement in tissue
perfusion of the foot immediately after tibial angioplasty. This
effect was not restricted to certain borders, such as the ones
defined by the angiosome concept [40]. Although this study
involved relatively small numbers and design flaws, the
findings provide food for thought about the presumption that
angiosome-based revascularization is crucial [41]. Achieving
the goal of optimal revascularization is more complicated
than it appears at first sight and collateral flow developed as a
response to chronic ischemia may lead to better trans-
angiosomal flow than would be anticipated. This fits with
the clinical observation that bypass to one part of the footmay
successfully treat tissue loss in another [41]. Not all studies
evaluating the angiosome concept came to the conclusion
that angiosome-directed revascularization is essential. The
evaluation of functional anatomy by means of intra-
procedural real-time analysis of foot perfusion may offer
better guidance to revascularization in the future [18].
Questions for the future remain how (using which type of
macro- and microcirculatory evaluation) and when (whichphase of reperfusion) direct revascularization will provide
consistent tissue regeneration to prove superiority over indi-
rect revascularization [37]. It will never be a matter of debate
that restoring pulsatile arterial flow to an ischemic block of
tissue promotes healing. Despite all of the recent research, it
remains unclear to what extent the angiosome model in-
fluences the choice of the revascularization strategy and de-
cision making and how this improves clinical outcomes. It is
without doubt that the angiosome model is able to steer de-
cision making, especially in conditions where one needs to
target one single artery (eg, in bypass surgery or in an attempt
to limit contrast load in patients with end-stage kidney fail-
ure). With the endovascular-first approach that is advocated
today for diabetic foot treatment, it is possible to perform
sequential revascularization of all arteries. This implies that
the choice of which artery to target first becomes less strin-
gent and therefore the angiosome model will be of less
importance. Furthermore, given the variations in anatomy
and the variable amount of collateral reserve, the predefined
anatomical, topographical angiosomes do not always corre-
spond to the actual distribution of flow. This underscores the
need for proper pre- or peroperative angiographic assessment
in order to reliably confirmwhich artery should be considered
as the feeding artery of a wound bed. The old angiosome
theory is here to stay, but should be part of a more holistic
approach that emphasizes functional revascularization of the
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